Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study.
Feijen EAM, Teepen JC, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Heiden-van der Loo M, van der Pal HJH, de Vries ACH, Louwerens M, Bresters D, Versluys B, de Ridder H, Veening M, van Leeuwen FE, Grootenhuis M, Maurice-Stam H, van Santen HM, Neggers SJCMM, Pluijm S, den Hartogh J, Ronckers CM, Tissing WJE, Loonen JJ, Kremer LCM. Feijen EAM, et al. Pediatr Blood Cancer. 2023 May;70(5):e30212. doi: 10.1002/pbc.30212. Epub 2023 Jan 18. Pediatr Blood Cancer. 2023. PMID: 36651687
Desire for children among male survivors of childhood cancer: A DCCSS LATER study.
Claessens JJM, Penson A, Bronkhorst EM, Kremer LCM, van Dulmen-den Broeder E, van der Heiden-van der Loo M, Tissing WJE, van der Pal HJH, Blijlevens NMA, van den Heuvel-Eibrink MM, Versluys AB, Bresters D, Ronckers CM, Walraven I, Beerendonk CCM, Loonen JJ; Dutch LATER Study Group. Claessens JJM, et al. Cancer. 2023 May 1;129(9):1432-1442. doi: 10.1002/cncr.34685. Epub 2023 Mar 7. Cancer. 2023. PMID: 36881488 Free article.
The Value of IgM Memory B-Cells in the Assessment of Splenic Function in Childhood Cancer Survivors at Risk for Splenic Dysfunction: A DCCSS-LATER Study.
Houtman BM, Walraven I, de Grouw E, van der Maazen RWM, Kremer LCM, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, Tissing WJE, Bresters D, van der Pal HJH, de Vries ACH, Louwerens M, van der Heiden-van der Loo M, Neggers SJC, Janssens GO, Blijlevens NMA, Lambeck AJA, Preijers F, Loonen JJ. Houtman BM, et al. J Immunol Res. 2023 Oct 20;2023:5863995. doi: 10.1155/2023/5863995. eCollection 2023. J Immunol Res. 2023. PMID: 37901347 Free PMC article.
The impact of clinically relevant health conditions on psychosocial outcomes in survivors of childhood cancer: results of the DCCSS-LATER study.
Maas A, Maurice-Stam H, Feijen LEAM, Teepen JC, van der Aa-van Delden AM, Streefkerk N, van Dulmen-den Broeder E, Tissing WJE, Loonen JJ, van der Pal HJH, de Vries ACH, van den Heuvel-Eibrink MM, Ronckers C, Neggers S, Bresters D, Louwerens M, Versluys BAB, van der Heiden-van der Loo M, Kremer LCM, Grootenhuis M; Dutch LATER study group. Maas A, et al. Among authors: van der heiden van der loo m. J Cancer Surviv. 2024 Jun 22. doi: 10.1007/s11764-024-01617-z. Online ahead of print. J Cancer Surviv. 2024. PMID: 38907800
Adverse late health outcomes among children treated with 3D radiotherapy techniques: Study design of the Dutch pediatric 3D-RT study.
Beijer JGM, Kok JL, Janssens GO, Streefkerk N, de Vries ACH, Slagter C, Maduro JH, Kroon PS, Grootenhuis MA, van Dulmen-den Broeder E, Loonen JJ, Wendling M, Tissing WJE, van der Pal HJ, Louwerens M, Bel A, den Hartogh J, van der Heiden-van der Loo M, Kremer LCM, Teepen JC, Ronckers CM. Beijer JGM, et al. Cancer Rep (Hoboken). 2023 Feb;6(2):e1620. doi: 10.1002/cnr2.1620. Epub 2023 Jan 30. Cancer Rep (Hoboken). 2023. PMID: 36715495 Free PMC article.
The cumulative burden of self-reported, clinically relevant outcomes in long-term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study.
Streefkerk N, Teepen JC, Feijen EAM, Jóźwiak K, van der Pal HJH, Ronckers CM, De Vries ACH, Van der Heiden-van Der Loo M, Hollema N, van den Berg M, Loonen J, Grootenhuis MA, Bresters D, Versluys AB, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van Leeuwen FE, Neggers SJCMM, Van Santen HM, Hawkins M, Hauptmann M, Yoneoka D, Korevaar JC, Tissing WJE, Kremer LCM; DCCSS LATER Study Group. Streefkerk N, et al. Cancer. 2024 Apr 15;130(8):1349-1358. doi: 10.1002/cncr.35148. Epub 2023 Dec 15. Cancer. 2024. PMID: 38100618
Introduction of sentinel node biopsy and stage migration of breast cancer.
van der Heiden-van der Loo M, Bezemer PD, Hennipman A, Siesling S, van Diest PJ, Bongers V, Peeters PH. van der Heiden-van der Loo M, et al. Eur J Surg Oncol. 2006 Sep;32(7):710-4. doi: 10.1016/j.ejso.2006.04.001. Epub 2006 Jun 9. Eur J Surg Oncol. 2006. PMID: 16765560
Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
Ho VK, van der Heiden-van der Loo M, Rutgers EJ, van Diest PJ, Hobbelink MG, Tjan-Heijnen VC, Dirx MJ, Reedijk AM, van Dijck JA, van de Poll-Franse LV, Schaapveld M, Peeters PH. Ho VK, et al. Eur J Cancer. 2008 Mar;44(5):683-91. doi: 10.1016/j.ejca.2008.01.027. Epub 2008 Mar 7. Eur J Cancer. 2008. PMID: 18314328
86 results